Real World Outcomes of CAR T-Cell Therapy in Multiple Myeloma Including Older and Comorbid Patients

Summary: Doctors are finding that a special cancer treatment called CAR T-cell therapy works just as well in the real world as it does in tests. This is great news for older patients with multiple myeloma, even those in their 70s and 80s. As long as their heart and lungs are strong, age is just a number!

Even if patients have other health issues like kidney problems or heart failure, doctors can easily adjust the treatment to keep them safe. The side effects are predictable and can be managed by a good medical team. This means many more people can get this life-saving treatment than originally thought.

For more details, see rssapp-cancernetwork-com at cancernetwork.com/view/real-world-outcomes-of-car-t-cell-therapy-in-multiple-myeloma-including-older-and-comorbid-patients (opens in new tab)